MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

La Jolla Pharmaceutical Company Company Profile (NASDAQ:LJPC)

Consensus Ratings for La Jolla Pharmaceutical Company (NASDAQ:LJPC) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $42.40 (153.13% upside)

Analysts' Ratings History for La Jolla Pharmaceutical Company (NASDAQ:LJPC)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016SunTrustInitiated CoverageBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016Lake Street CapitalInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2016Cowen and CompanyInitiated CoverageOutperform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Noble FinancialReiterated RatingBuy$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/8/2015Chardan CapitalBoost Price TargetBuy$60.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015HC WainwrightLower Price TargetBuy$29.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015OppenheimerInitiated CoverageOutperform$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2014WedbushReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for La Jolla Pharmaceutical Company (NASDAQ:LJPC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/5/2016        
5/6/2016Q416($0.74)($0.96)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2015Q315($0.71)($0.70)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2015Q215($0.61)($0.70)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015Q414($0.37)($0.45)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2014Q314($0.31)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/14/2014Q214($0.69)($0.63)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2014($0.91)($0.93)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/31/2014($0.24)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for La Jolla Pharmaceutical Company (NASDAQ:LJPC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.95)($0.95)($0.95)
Q3 20161($0.95)($0.95)($0.95)
Q4 20161($0.81)($0.81)($0.81)
(Data provided by Zacks Investment Research)
Dividend History for La Jolla Pharmaceutical Company (NASDAQ:LJPC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for La Jolla Pharmaceutical Company (NASDAQ:LJPC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/4/2016Kevin C TangDirectorBuy20,000$19.85$397,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/1/2016George F TidmarshCEOBuy2,000$16.57$33,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/28/2015Lakhmir S ChawlaInsiderBuy485$27.75$13,458.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2015Kevin C TangDirectorBuy80,000$38.00$3,040,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2015Kevin C TangDirectorBuy170,000$27.11$4,608,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2015Kevin C TangDirectorBuy110,000$23.58$2,593,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2015Kevin C TangDirectorBuy220,000$22.23$4,890,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2015Kevin C TangDirectorBuy53,836$22.27$1,198,927.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015Kevin C TangDirectorBuy77,850$21.41$1,666,768.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2015Kevin C TangDirectorBuy190,583$18.24$3,476,233.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2015George F TidmarshCEOBuy4,000$18.37$73,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Kevin C TangDirectorBuy232,343$12.84$2,983,284.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2014George F TidmarshCEOBuy4,000$11.38$45,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/26/2014George F TidmarshCEOBuy2,000$9.35$18,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/26/2014Kevin C TangDirectorBuy169,555$9.14$1,549,732.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2014Kevin C TangDirectorBuy30,500$9.17$279,685.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2014Kevin C TangDirectorBuy95,000$9.10$864,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2014George F TidmarshCEOBuy5,000$9.18$45,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2014George F TidmarshCEOBuy19,000$10.50$199,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2014George TidmarshCEOBuy12,000$7.37$88,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2014George TidmarshCEOBuy8,000$9.53$76,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014George F TidmarshCEOBuy3,000$7.25$21,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for La Jolla Pharmaceutical Company (NASDAQ:LJPC)
DateHeadline
06/24/16 04:57 PMShare Volatility Check for: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Press Telegraph
06/24/16 07:37 AMLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Earnings Glance and Target Price Review - Engelwood Daily
06/22/16 03:02 PMAnalyst Update: T2 Biosystems Inc, La Jolla Pharmaceutical Company, and Illumina, Inc.
06/21/16 04:38 PMStrong Buy Calls Count For La Jolla Pharmaceutical Company (NASDAQ:LJPC) At 5 - Investor Newswire
06/20/16 07:09 AMLa Jolla Pharmaceutical Company (LJPC) Analyst Price Targets For The Coming Week - Fiscal Standard
06/17/16 07:06 AMLa Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : June 17, 2016 -
06/06/16 04:52 PMLa Jolla Pharmaceutical Company to Provide Corporate Overview at the Jefferies 2016 Global Healthcare Conference - Business Wire (press release)
06/06/16 04:52 PMLA JOLLA PHARMACEUTICAL CO. (NASDAQ:LJPC) Financial Condition Compared to S&P 500 - CML News
06/06/16 07:18 AMLa Jolla Pharmaceutical Company to Provide Corporate Overview at the Jefferies 2016 Global Healthcare Conference - [at noodls] - SAN DIEGO-(BUSINESS WIRE)- La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients ...
06/04/16 07:44 AMLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Stock Update & Estimates - Stock Tick Tock
06/01/16 05:23 PMBiotech Daily Digest: The Biotech Rally Continues; Another Small Cap Gets Bought Out; Icahn Targets Allergan - La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The company ...
05/29/16 12:06 AMTang Capital Management LLC Increased La Jolla Pharmaceutical Co (NASDAQ:LJPC) by $3.60 Million as Shares ... - CCH Daily News - Tang Capital Management LLC Increased La Jolla Pharmaceutical Co (NASDAQ:LJPC) by $3.60 Million as Shares ...CCH Daily NewsKevin C. Tang increased its stake in La Jolla Pharmaceutical Co (NASDAQ:LJPC) by 6.27% based on its latest 2016Q1 regulatory filing with the SEC. Tang Capital Management Llc bought 180,000 shares as the company's stock declined 16.56% while stock ...La Jolla Pharmaceutical Company (LJPC) Updated Analyst CoverageRisers & FallersAre Analysts Bearish La Jolla Pharmaceutical Company (NASDAQ:LJPC) After Last Week?HNNall 3 news articles »
05/26/16 07:22 PMVenbio Select Advisor LLC Decreased Stake in La Jolla Pharmaceutical Co. (NASDAQ:LJPC) by $11.45 Million as ... - CCH Daily News - Venbio Select Advisor LLC Decreased Stake in La Jolla Pharmaceutical Co. (NASDAQ:LJPC) by $11.45 Million as ...CCH Daily NewsVenbio Select Advisor Llc decreased its stake in La Jolla Pharmaceutical Co. (NASDAQ:LJPC) by 73.01% based on its latest 2016Q1 regulatory filing with the SEC. Venbio Select Advisor Llc sold 572,527 shares as the company's stock declined 16.56% while ...and more »
05/25/16 06:57 PMInsiders Are Gradually Buying La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Wall Street Hints and News - Insiders Are Gradually Buying La Jolla Pharmaceutical Co. (NASDAQ:LJPC)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at La Jolla Pharmaceutical Co. (NASDAQ:LJPC) have increased their position in the stock by 1.64% over the past 6 months. Insiders now own 7.80% of total outstanding shares. There are both legal and illegal ...and more »
05/24/16 07:41 AMCoverage initiated on La Jolla Pharm by Lake Street -
05/18/16 07:03 PMRevenue Update on La Jolla Pharmaceutical Company(NASDAQ:LJPC) - Trade Calls - Revenue Update on La Jolla Pharmaceutical Company(NASDAQ:LJPC)Trade CallsLa Jolla Pharmaceutical Company(NASDAQ:LJPC) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 6, 2016. Company reported revenue of $234.00K. Analysts estimated a revenue of $210.00K.La Jolla Pharmaceutical Company (NASDAQ:LJPC) Reports Basic Consolidated EPS At $-2.6779Markets Dailyall 2 news articles »
05/16/16 06:45 PMVenbio Select Advisor Llc Decreased Stake in La Jolla Pharmaceutical Co. (NASDAQ:LJPC) by $11.45 Million as ... - Wall Street Hints and News - Venbio Select Advisor Llc Decreased Stake in La Jolla Pharmaceutical Co. (NASDAQ:LJPC) by $11.45 Million as ...Wall Street Hints and NewsVenbio Select Advisor Llc decreased its stake in La Jolla Pharmaceutical Co. (NASDAQ:LJPC) by 73.01% based on its latest 2016Q1 regulatory filing with the SEC. Venbio Select Advisor Llc sold 572,527 shares as the company's stock declined 16.56% while ...and more »
05/13/16 07:26 PMLatest Analyst Ratings For La Jolla Pharmaceutical Company (LJPC) - Share Trading News - Latest Analyst Ratings For La Jolla Pharmaceutical Company (LJPC)Share Trading News01/15/2016 – Noble Financial began new coverage on La Jolla Pharmaceutical Company giving the company a “buy” rating. They now have a USD 37 price target on the stock. 09/08/2015 – La Jolla Pharmaceutical Company had its “buy” rating reiterated by ...La Jolla Pharmaceutical Company (NASDAQ:LJPC) Basic Consolidated EPS At $-2.6779Markets Dailyall 2 news articles »
05/12/16 07:59 PMPerformance Recap and Target Perspective on La Jolla Pharmaceutical Company (NASDAQ:LJPC) - B.O.D.Y Confidential - Performance Recap and Target Perspective on La Jolla Pharmaceutical Company (NASDAQ:LJPC)B.O.D.Y ConfidentialIn the latest trading session, shares of La Jolla Pharmaceutical Company (NASDAQ:LJPC) moved -1.92%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent ...and more »
05/09/16 05:29 AMPico reports 1Q loss -
05/09/16 02:31 AMABT Hits The Right Note, AVXS Walks The Talk, STEM Splits, LJPC Awaits Data - STEM closed Friday's trading at $0.24, down 12.73%. La Jolla Pharmaceutical Co.'s ( LJPC) phase III trial of LJPC-501 in catecholamine-resistant hypotension, dubbed ATHOS, is underway, and results are expected by the end of 2016. The full results from a ...
05/06/16 07:47 PMLa Jolla Pharmaceutical Company Announces First Quarter 2016 Financial Results and Recent Corporate Progress - Business Wire (press release) - Web Breaking NewsLa Jolla Pharmaceutical Company Announces First Quarter 2016 Financial Results and Recent Corporate ProgressBusiness Wire (press release)SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening ...La Jolla Pharmaceutical Company (LJPC) Posts Quarterly Earnings Results, Misses Estimates By $0.22 EPSWeb Breaking NewsLa Jolla Pharmaceutical Posts Wider Q1 Loss Vs. Estimates, Revenue In Line – Shares off 5% (NASDAQ:LJPC)Sonoran Weekly ReviewLa Jolla Pharmaceutical posts 1Q lossMoney Morningall 4 news articles »
05/06/16 03:54 PMLa Jolla Pharmaceutical Company Announces First Quarter 2016 Financial Results and Recent Corporate Progress - [at noodls] - SAN DIEGO-(BUSINESS WIRE)- La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients ...
05/06/16 08:07 AMLa Jolla Pharmaceutical posts 1Q loss -
05/06/16 05:04 AMLA JOLLA PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report -
05/05/16 08:27 PMAverage Analyst Rating for La Jolla Pharmaceutical Company (NASDAQ:LJPC) - B.O.D.Y Confidential - Average Analyst Rating for La Jolla Pharmaceutical Company (NASDAQ:LJPC)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1 on La Jolla Pharmaceutical Company (NASDAQ:LJPC) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks ...and more »
05/02/16 02:24 AMLa Jolla Pharmaceutical Company (LJPC) Broker Price Targets For The Coming Week - Share Trading News - La Jolla Pharmaceutical Company (LJPC) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of La Jolla Pharmaceutical Company (LJPC). The latest reports which are currently in issue on Monday 2nd of May state 0 analysts have a rating of “strong buy”, 0 analysts ...
04/28/16 08:55 PMLa Jolla Pharmaceutical Company (LJPC) Updated Broker Price Targets - Share Trading News - La Jolla Pharmaceutical Company (LJPC) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of La Jolla Pharmaceutical Company (LJPC). The latest reports which are currently in issue on Thursday 28th of April state 0 analysts have a rating of “strong buy”, 0 ...and more »
04/27/16 08:23 PMShare Performance and Target Price Review La Jolla Pharmaceutical Company (NASDAQ:LJPC) - B.O.D.Y Confidential - Share Performance and Target Price Review La Jolla Pharmaceutical Company (NASDAQ:LJPC)B.O.D.Y ConfidentialDuring the most recent trading session, shares of La Jolla Pharmaceutical Company (NASDAQ:LJPC) ended up with a move of +0.57%. Sell-side analysts have given a consensus target price of $46.25 on company shares. Target price projections may differ ...and more »
04/26/16 07:22 PMAnalyst Coverage: La Jolla Pharmaceutical Company (LJPC) - Risers & Fallers - Analyst Coverage: La Jolla Pharmaceutical Company (LJPC)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of La Jolla Pharmaceutical Company (LJPC). The latest broker reports which are currently outstanding on Tuesday 26th of April state 0 analysts have a rating of “strong buy”, ...
04/26/16 03:08 AMLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Share Rating Recap - The Post - La Jolla Pharmaceutical Company (NASDAQ:LJPC) Share Rating RecapThe PostShares of La Jolla Pharmaceutical Company (NASDAQ:LJPC) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes ...and more »
04/25/16 10:00 PMLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Wall Street Rating in Focus - News Tribune - La Jolla Pharmaceutical Company (NASDAQ:LJPC) Wall Street Rating in FocusNews TribuneZacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 4 equity research firms that cover shares of La Jolla Pharmaceutical Company ...and more »
04/24/16 09:58 PMNext Weeks Broker Price Targets For La Jolla Pharmaceutical Company (LJPC) - Share Trading News - Next Weeks Broker Price Targets For La Jolla Pharmaceutical Company (LJPC)Share Trading News01/15/2016 – Noble Financial began new coverage on La Jolla Pharmaceutical Company giving the company a “buy” rating. They now have a USD 37 price target on the stock. 09/08/2015 – La Jolla Pharmaceutical Company had its “buy” rating reiterated by ...
04/22/16 09:23 PMBroker Outlook For La Jolla Pharmaceutical Company (LJPC) - Share Trading News - Broker Outlook For La Jolla Pharmaceutical Company (LJPC)Share Trading NewsIts four product candidates in development include LJPC-501, GCS-100, LJPC-1010 and LJPC-401. LJPC-501 is its formulation of angiotensin for the treatment of catecholamine-resistant hypotension (CRH). GCS-100 is its galectin-3 inhibitor for the ...
04/22/16 09:23 PMLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Has An Average Rating Of 4.5 - Investor Newswire - La Jolla Pharmaceutical Company (NASDAQ:LJPC) Has An Average Rating Of 4.5Investor NewswireAlpha One uses algorithm-based analytics to know about a stock sentiment varying as per the published content on online channels. In this analysis, the group considers only the most relevant news sources on a daily basis. La Jolla Pharmaceutical ...and more »
04/22/16 09:23 PMLa Jolla Pharmaceutical Company (LJPC) Latest Broker Views - Risers & Fallers - La Jolla Pharmaceutical Company (LJPC) Latest Broker ViewsRisers & FallersA number of investment brokers have recently updated their price targets on shares of La Jolla Pharmaceutical Company (LJPC). According to the latest broker reports outstanding on Friday 22nd of April, 0 analysts have a rating of “strong buy”, 0 ...Were Analysts Bullish La Jolla Pharmaceutical Company (NASDAQ:LJPC) This Week?The Postall 2 news articles »
04/21/16 09:07 PMCan Shares Of La Jolla Pharmaceutical Company (NASDAQ:LJPC) Hit $80? - Investor Newswire - Can Shares Of La Jolla Pharmaceutical Company (NASDAQ:LJPC) Hit $80?Investor NewswireThe Buy recommendations for La Jolla Pharmaceutical Company (NASDAQ:LJPC) stock is 0, sell recommendations at 0 and hold recommendations count at 0. It boasts a total of 4 Strong Buy calls and 0 Strong Sell calls as of 2016-04-21. One month ago, the ...and more »
04/20/16 03:00 AMLa Jolla Pharmaceutical Company (LJPC) - Broker Update - Risers & Fallers - La Jolla Pharmaceutical Company (LJPC) - Broker UpdateRisers & FallersLa Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening diseases. Its four product ...
04/18/16 09:27 PMLa Jolla Pharmaceutical Company (NASDAQ:LJPC): Where are Shares Headed? - News Tribune - La Jolla Pharmaceutical Company (NASDAQ:LJPC): Where are Shares Headed?News TribuneResearch analysts covering La Jolla Pharmaceutical Company (NASDAQ:LJPC) shares have provided price target projections on the popular stock. They project that the shares are expected to reach $46.25 within the upcoming year. This consensus number ...and more »
04/15/16 08:53 PMEarnings Watch on La Jolla Pharmaceutical Company (NASDAQ:LJPC) - RiversideGazette.com - Earnings Watch on La Jolla Pharmaceutical Company (NASDAQ:LJPC)RiversideGazette.comLa Jolla Pharmaceutical Company (NASDAQ:LJPC) has a consensus earnings per share estimate for the current quarter of $-0.77 based on compiled analyst projections. The company is next expected to release earnings on or around 2016-05-04 for the ...
04/14/16 09:45 PMView on Ratings La Jolla Pharmaceutical Company (NASDAQ:LJPC) - Business Standard Tribune - View on Ratings La Jolla Pharmaceutical Company (NASDAQ:LJPC)Business Standard TribuneUsing a scale from 1 to 5, La Jolla Pharmaceutical Company (NASDAQ:LJPC) has a rating of 1 on the stock. A score of 1 or 2 indicates a Buy rating, and a score of 4 or 5 indicates a Sell rating. A 3 would indicate a Hold. This consensus number is made ...and more »
04/13/16 08:08 PMHow Analysts Feel About La Jolla Pharmaceutical Company (NASDAQ:LJPC)? - RiversideGazette.com - How Analysts Feel About La Jolla Pharmaceutical Company (NASDAQ:LJPC)?RiversideGazette.comOut of 4 analysts covering La Jolla Pharmaceutical Company (NASDAQ:LJPC), 4 rate it “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. La Jolla Pharmaceutical Company was the topic in 3 analyst reports since August 11, 2015 according to ...
03/31/16 11:24 PMLa Jolla, Calif. Beachfront Home With Blue Dome Seeks Nearly $27 Million -
03/07/16 03:53 PMThe Most Notable Insider Buys And Sells Of Last Week -
03/04/16 12:04 PMLA JOLLA PHARMACEUTICAL CO Financials -
03/03/16 07:15 AMLa Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : March 3, 2016 -
03/03/16 07:00 AMLa Jolla Pharmaceutical Company to Provide Corporate Overview at the Cowen and Company 36th Annual Health Care Conference - [Business Wire] - La Jolla Pharmaceutical Company , a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that the Company will provide a corporate overview at the Cowen and Company 36th Annual Health Care Conference taking place March 7–9 in Boston.
03/02/16 03:23 PMLA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an -
02/26/16 06:27 AMOrexigen reports 4Q loss -
02/25/16 03:40 PMLa Jolla Pharmaceutical Company Announces Fourth Quarter and Full Year 2015 Financial Results and Highlights Corporate Progress - [Business Wire] - La Jolla Pharmaceutical Company , a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today reported fourth quarter and full year 2015 financial results and highlighted 2015 corporate progress.
About La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company logoLa Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening diseases. Its four product candidates in development include LJPC-501, GCS-100, LJPC-1010 and LJPC-401. LJPC-501 is its formulation of angiotensin for the treatment of catecholamine-resistant hypotension (CRH). GCS-100 is its galectin-3 inhibitor for the potential treatment of chronic kidney disease. LJPC-1010 is its galectin-3 inhibitor. LJPC-401 is its formulation of hepcidin for the potential treatment of conditions characterized by iron overload, such as hemochromatosis and beta thalassemia.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: LJPC
  • CUSIP:
Key Metrics:
  • Previous Close: $16.75
  • 50 Day Moving Average: $16.39
  • 200 Day Moving Average: $19.11
  • P/E Ratio: N/A
  • P/E Growth: -0.35
  • Market Cap: $305.75M
  • Current Quarter EPS Consensus Estimate: $-3.99 EPS
Additional Links:
La Jolla Pharmaceutical Company (NASDAQ:LJPC) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha